Table 2 Comparison of biomarkers according to survival status
Biomarkers | BALF | Serum | ||
|---|---|---|---|---|
ARDS survivors (n = 31) | ARDS non-survivors (n = 21) | ARDS survivors (n = 31) | ARDS non-survivors (n = 21) | |
ATX (ng/mL) | 3.19 ± 4.43 | 3.04 ± 3.46 | 35.09 ± 13.89 | 44.79 ± 13.38* |
IL-6 (ng/mL) | 0.39 ± 0.56 | 0.61 ± 0.63 | 0.89 ± 3.83 | 0.97 ± 2.01 |
IL-8 (ng/mL) | 3136.77 ± 1915.69 | 4618.65 ± 2776.99* | 258.76 ± 735.09 | 314.47 ± 478.16 |
TNF-α (pg/mL) | 13.27 (8.00-51.13) | 35.56 (9.47-192.87) | 12.04 (8.20-23.99) | 14.72 (6.17-37.86) |
MMP-7 (ng/mL) | 34.03 ± 28.85 | 46.30 ± 43.18 | 4.81 (2.75-7.76) | 8.02 (4.43-16.73) * |
Fibronectin (ug/mL) | 1.12 ± 1.74 | 1.12 ± 1.65 | 72.26 ± 111.07 | 78.21 ± 98.01 |
OSM (ng/mL) | 0.93 ± 0.66 | 1.22 ± 0.76 | 3.65 ± 3.81 | 3.83 ± 5.25 |
SPARC (ng/mL) | 19.50 ± 56.28 | 15.84 ± 37.57 | 1.33 ± 0.92 | 1.03 ± 0.12 |